These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21073964)

  • 1. Where in-vivo imaging meets cytoarchitectonics: the relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET.
    la Fougère C; Grant S; Kostikov A; Schirrmacher R; Gravel P; Schipper HM; Reader A; Evans A; Thiel A
    Neuroimage; 2011 Jun; 56(3):951-60. PubMed ID: 21073964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
    Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
    Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grey matter density and GABAA binding potential show a positive linear relationship across cortical regions.
    Duncan NW; Gravel P; Wiebking C; Reader AJ; Northoff G
    Neuroscience; 2013 Apr; 235():226-31. PubMed ID: 23380503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
    Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
    Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuronal component of gray matter damage in multiple sclerosis: A [(11) C]flumazenil positron emission tomography study.
    Freeman L; Garcia-Lorenzo D; Bottin L; Leroy C; Louapre C; Bodini B; Papeix C; Assouad R; Granger B; Tourbah A; Dollé F; Lubetzki C; Bottlaender M; Stankoff B
    Ann Neurol; 2015 Oct; 78(4):554-67. PubMed ID: 26292991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal neuronal damage in patients with neuropsychological impairment after diffuse traumatic brain injury: evaluation using ¹¹C-flumazenil positron emission tomography with statistical image analysis.
    Kawai N; Maeda Y; Kudomi N; Yamamoto Y; Nishiyama Y; Tamiya T
    J Neurotrauma; 2010 Dec; 27(12):2131-8. PubMed ID: 21138392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke.
    Heiss WD; Grond M; Thiel A; Ghaemi M; Sobesky J; Rudolf J; Bauer B; Wienhard K
    Stroke; 1998 Feb; 29(2):454-61. PubMed ID: 9472889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: a 11C-flumazenil PET study.
    Yamauchi H; Kudoh T; Kishibe Y; Iwasaki J; Kagawa S
    J Nucl Med; 2005 Dec; 46(12):1973-9. PubMed ID: 16330559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy.
    Padma MV; Simkins R; White P; Satter M; Christian BT; Dunigan K; Lee C; Jacobs M; Mukherjee J; Mantil JC
    Neurol India; 2004 Dec; 52(4):457-62. PubMed ID: 15626833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study.
    Richardson MP; Koepp MJ; Brooks DJ; Fish DR; Duncan JS
    Ann Neurol; 1996 Aug; 40(2):188-98. PubMed ID: 8773600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: a comparative positron emission tomography/magnetic resonance imaging study in early ischemic stroke.
    Heiss WD; Sobesky J; Smekal Uv; Kracht LW; Lehnhardt FG; Thiel A; Jacobs AH; Lackner K
    Stroke; 2004 Aug; 35(8):1892-8. PubMed ID: 15218157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects.
    Frankle WG; Cho RY; Narendran R; Mason NS; Vora S; Litschge M; Price JC; Lewis DA; Mathis CA
    Neuropsychopharmacology; 2009 Feb; 34(3):624-33. PubMed ID: 18615011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.
    Turner MR; Hammers A; Al-Chalabi A; Shaw CE; Andersen PM; Brooks DJ; Leigh PN
    Brain; 2005 Jun; 128(Pt 6):1323-9. PubMed ID: 15843422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: a positron emission tomography study.
    Ihara M; Tomimoto H; Ishizu K; Mukai T; Yoshida H; Sawamoto N; Inoue M; Doi T; Hashikawa K; Konishi J; Shibasaki H; Fukuyama H
    Stroke; 2004 Apr; 35(4):942-7. PubMed ID: 15001785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing neuronal density in peri-infarct cortex with PET: Effects of cortical topology and partial volume correction.
    Funck T; Al-Kuwaiti M; Lepage C; Zepper P; Minuk J; Schipper HM; Evans AC; Thiel A
    Hum Brain Mapp; 2017 Jan; 38(1):326-338. PubMed ID: 27614005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [11C]Flumazenil PET in patients with epilepsy with dual pathology.
    Juhász C; Nagy F; Muzik O; Watson C; Shah J; Chugani HT
    Epilepsia; 1999 May; 40(5):566-74. PubMed ID: 10386525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.
    Turner MR; Osei-Lah AD; Hammers A; Al-Chalabi A; Shaw CE; Andersen PM; Brooks DJ; Leigh PN; Mills KR
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1279-85. PubMed ID: 16107368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy.
    Vivash L; Gregoire MC; Bouilleret V; Berard A; Wimberley C; Binns D; Roselt P; Katsifis A; Myers DE; Hicks RJ; O'Brien TJ; Dedeurwaerdere S
    PLoS One; 2014; 9(1):e86722. PubMed ID: 24466212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ketogenic diet may control seizures by increasing the binding potential of the benzodiazepine receptor: a speculation from the [11C] flumazenil-PET study].
    Kumada T; Nishii R; Higashi T; Miyajima T; Oda N; Shimomura H; Saito K; Fujii T
    No To Hattatsu; 2012 Jan; 44(1):50-4. PubMed ID: 22352031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased chronic-stage cortical 11C-flumazenil binding after focal ischemia-reperfusion in baboons: a marker of selective neuronal loss?
    Giffard C; Landeau B; Kerrouche N; Young AR; Barré L; Baron JC
    Stroke; 2008 Mar; 39(3):991-9. PubMed ID: 18239185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.